Schizophrenia Trial, Recruiting NCT06649552 Sponsor: Centre Psychothérapique de Nancy Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06649552
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People being seen at one of three specific mental health centres in France (CLIP-Ado Nancy, CH Alpes-Isère, or CHRU Lille) for signs that may suggest a risk of developing psychosis, as assessed using specific clinical tools called the CAARMS scale and/or the SPI-CY scale.
  • Adolescents aged between 12 years old and 17 years and 11 months.
  • People enrolled in, or covered by, the French social security system.
  • People whose first language is French.
  • Adolescents who have been given information about the study and have not objected to taking part.
  • At least one parent or legal guardian who has been informed about the study and has not objected to the adolescent's participation.
  • Adolescents and at least one parent who agree to having the SPI-CY assessment session audio recorded.

Who may not be able to join:

  • People who are pregnant, recently given birth, or currently breastfeeding.
  • People who are under court-ordered or government-ordered detention or restriction of freedom.
  • People who are currently in a life-threatening emergency situation.
  • People whose health or abilities make it very difficult or impossible to take part in the trial or to understand the information provided.
  • People who meet the clinical criteria for serious misuse of or dependence on substances (other than cannabis), as defined by the DSM-5 diagnostic guidelines.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Florent BERNARDIN, Centre Psychothérapique de Nancy (CPN)

Phone: 0033 3 83 26 08 63

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Psychothérapique de Nancy
Registry
ClinicalTrials.gov
Start date
13 February 2025
Est. completion
13 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

SPI-CY assessment : Schizophrenia Proneness Instrument - Child and Youth version

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov